NC6 Nanollose Limited
—Mkt Cap: —P/E: —1d ago
Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia. The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre …
Industry Peers
Biotechnology$128.87BUSDP/E 29.6
$94.42BUSD
$81.99BUSDP/E 19.1
$53.47BUSDP/E 32.5
$53.22BUSDP/E 31.6
$44.02BUSDP/E 17.8
$42.56BUSDP/E 66.4
$40.57BUSD
$34.45BUSDP/E 30.4
$31.32BUSDP/E 39.3
$24.59BUSD
$23.32BUSDP/E 31.7
$23.26BUSDP/E 29.8
$22.96BUSDP/E 14.0
$22.66BUSD
$21.67BUSD
$15.57BUSDP/E 19.3
$14.91BUSDP/E 17.4
$13.92BUSDP/E 14.7
$13.79BUSDP/E 33.4
Key Statistics
Company
Market Cap—
Enterprise Value18.59M USD
Revenue (TTM)214.97K USD
Gross Profit-350.22K USD
Net Income (TTM)-985.80K USD
Revenue/Share0.0010 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000NC68
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-11.28
EV/Revenue86.46
P/S90.91
P/B23.00
EPS (TTM)-0.01
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin-162.91%
Oper. Margin-276.59%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-359.84%
ROA-190.76%
Growth
Revenue Growth31.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.24M USD
CapEx (TTM)—
FCF Margin-291.76%
FCF Yield—
Net Debt-915.66K USD
Net Debt/EBITDA0.56
Balance Sheet
Debt/Equity0.03
Current Ratio6.29
Quick Ratio6.00
Book Value/Sh0.0030 AUD
Cash/Share0.0030 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.409.83M
Float171.93M
Insiders43.19%
Institutions14.65%
Technical
SMA 500.0757 AUD
SMA 2000.0711 AUD
Beta0.74
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)37.86K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—